Suzuki Sachiko | Pharmacokinetics, Dynamics & Metabolism, Global Research & Development, Nagoya Laboratories, Pfizer Japan, Inc., Japan

スポンサーリンク

概要

• Shimozono Riekoの詳細を見る
• 同名の論文著者
• Pharmacokinetics, Dynamics & Metabolism, Global Research & Development, Nagoya Laboratories, Pfizer Japan, Inc., Japanの論文著者

Pharmacokinetics, Dynamics & Metabolism, Global Research & Development, Nagoya Laboratories, Pfizer Japan, Inc., Japan | 論文

• Orally-Administered Caspase Inhibitor PF-03491390 Is Retained in the Liver for Prolonged Periods With Low Systemic Exposure, Exerting a Hepatoprotective Effect Against .ALPHA.-Fas-Induced Liver Injury in a Mouse Model

もっと見る

スポンサーリンク